(MENAFN- GlobeNewsWire - Nasdaq) SNS Insider projects the U.S. Enzyme-Linked Immunosorbent Assay (ELISA) Market to grow from USD 0.71 billion in 2025E to USD 1.10 billion by 2033, at a CAGR of 5.69%.